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Abstract
Background: Two-Dimensional Difference In Gel Electrophoresis (2D-DIGE) is a powerful tool for measuring differences in protein
expression between samples or conditions. However, to remove systematic variability within and between gels the data has to be
normalized.
In this study we examined the ability of four existing and four novel normalization methods to remove systematic bias in data produced
with 2D-DIGE. We also propose a modification of an existing method where the statistical framework determines whether a set of
proteins shows an association with the predefined phenotypes of interest. This method was applied to our data generated from a monkey
model (Macaca fascicularis) of Parkinson's disease.
Results: Using 2D-DIGE we analysed the protein content of the striatum from 6 control and 21 MPTP-treated monkeys, with or without
de novo or long-term L-DOPA administration.
There was an intensity and spatial bias in the data of all the gels examined in this study. Only two of the eight normalization methods
evaluated ('2D loess+scale' and 'SC-2D+quantile') successfully removed both the intensity and spatial bias. In 'SC-2D+quantile' we
extended the commonly used loess normalization method against dye bias in two-channel microarray systems to suit systems with three
or more channels.
Further, by using the proposed method, Differential Expression in Predefined Proteins Sets (DEPPS), several sets of proteins associated
with the priming effects of L-DOPA in the striatum in parkinsonian animals were identified. Three of these sets are proteins involved in
energy metabolism and one set involved proteins which are part of the microtubule cytoskeleton.
Conclusion: Comparison of the different methods leads to a series of methodological recommendations for the normalization and the
analysis of data, depending on the experimental design. Due to the nature of 2D-DIGE data we recommend that the p-values obtained in
significance tests should be used as rankings only. Individual proteins may be interesting as such, but by studying sets of proteins the
interpretation of the results are probably more accurate and biologically informative.
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Background
Proteomic techniques are important tools for studying the
mechanisms of a disease, pinpointing new therapeutic tar-
gets or finding potential biomarkers. The field of pro-
teomics is ever expanding and today there are several
techniques available for protein separation, both gel
based and non-gel based. Traditionally two-dimensional
polyacrylamide gel electrophoresis (2D-PAGE) has been
the technique used for protein separation. In 2D-PAGE
proteins first undergo isoelectric focusing (IEF) based on
their net charge, then an orthogonal second dimension is
applied to further separate proteins based on their molec-
ular weight, in the presence of denaturing conditions. In
this way it is possible to resolve several thousand proteins
in a single sample. 2D-PAGE mainly produces data which
enables the investigator to determine whether a particular
protein shows an increase or decrease when comparing
two different conditions e.g. a diseased state compared to
a non-diseased state. The limited dynamic range and poor
reproducibility between gels has been of major concern
with traditional 2D-PAGE experiments.
The task of detecting changes in protein expression has
recently been facilitated by the introduction of difference
in gel electrophoresis (DIGE)[1,2]. Gels using the 2D-
DIGE method usually contain three samples labeled with
three distinct fluorescent dyes, Cy2, Cy3 and Cy5. The Cy2
dye is typically used to label an internal standard which is
a mix of all samples in the experiment and the other two
dyes are usually used to label two biological samples of
interest. The strength of the internal standard is to help
the mapping of spots/proteins between gels and thus
make the different gels more comparable. The internal
standard is also used in some methods for normalization
within and between gels. The 2D-DIGE has been commer-
cialized through the Ettan DIGE System of Amersham
Biosciences (now GE Healthcare).
Fluorescent dyes, most commonly Cy3 and Cy5, have
been used extensively in gene expression microarray tech-
nologies to measure differences in gene expression. Using
cDNA microarrays there is a need for proper normaliza-
tion in order to remove systematic variation, within and
sometimes between arrays, and a need for proper test sta-
tistics to exploit the information across genes [3-8].
Since the data generated from 2D-DIGE experiments
exhibits similar characteristics to that obtained from
cDNA gene expression microarrays, some methods have
evolved for normalization of data produced with 2D-
DIGE based on methods in gene expression analysis
[9,10]. These methods focus on the intensity bias within
and between gels, paying little attention to spatial bias
within gels. Spatial bias is known to be a source of varia-
tion in gene expression microarrays [8].
In a gel set using 2D-DIGE we examined spatial and inten-
sity bias removal by eight different normalization meth-
ods. The commercial software available from GE
Healthcare (DeCyder) provides two of the methods, two
of the methods have been used on 2D-DIGE data before
[9,10], two methods have not been used on 2D-DIGE data
before, but have been used on gene expression microarray
data [3,8] and the final two are single channel analysis
approaches which have not been used on 2D-DIGE data
previously.
Most 2D-DIGE data analysis has focused on finding single
proteins with a changed expression between two different
conditions and tested for significant differences between
the means or medians in the different groups. To our
knowledge the most common approaches are those of
two-sample t-tests, their extensions within the scope of
analysis of variance (ANOVA) [11] and Generalized Lin-
ear Models (GLM) [12], and moderated t-statistics
[6,9,13].
The issue of significance level correction in multiple
hypothesis tests has been extensively discussed in the field
of gene expression microarrays. In proteomics studies, we
and others have used methods correcting the observed sig-
nificance levels using false discovery rate (FDR) [9,13].
There are several similarities between data obtained from
gene expression and proteins (2D-DIGE), but there are
also aspects of the data that have to be taken into account.
To a single protein there may be different chemical moie-
ties attached or removed by various enzymes, also known
as post-translational modification (PTM). This causes a
change in the protein mass and charge. As a result a pro-
tein originating from the same gene-product but with dif-
ferent modifications may be found in several different
positions in the gels. A treatment effect on a protein may
therefore cause a change of level of the unmodified pro-
tein and/or a change in level for a certain PTM-protein. It
is difficult to know whether these actions are co-regulated
or not, but as a consequence the use of FDR may be inap-
propriate since it assumes independent observations.
Instead we propose the use of an alternative method
which produces cut-off levels on the basis of permutation
tests.
Although single differentially expressed spots/proteins
can be informative, we are primarily interested in the
activity profiles of sets  of functionally related proteins.
Therefore, we also perform re-sampling-based tests on
predefined sets of proteins. Our protein set test is in line
with gene set tests suggested by Subramanian [14] and
Tian [15]. We adapted their method to suit protein data
and have named it Differential Expression in Predefined
Protein Sets (DEPPS).BMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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Parkinson's disease is a progressive neurodegenerative dis-
order which is characterized by the degeneration of
dopaminergic neurons of the substantia nigra, causing a
reduction in striatal dopamine content. Dopamine
replacement by L-DOPA is the most common treatment
resulting in an initial positive symptomatic response.
Unfortunately, long-term L-DOPA therapy is associated
with the development of motor complications such as
dyskinesia. After 4–6 years of L-DOPA treatment approxi-
mately 40% of patients have developed dyskinesia [16].
Once exposed to L-DOPA therapy, some patients are
'primed' and some will eventually develop dyskinesia
even if switched to a drug that in itself does not induce
dyskinesia when administered de novo [17]. Dyskinesia
contributes to the disability experienced by patients and it
is therefore of great importance to understand the mecha-
nisms of L-DOPA induced dyskinesia.
In this report we analyze the protein content in the stria-
tum from the gold-standard animal (Macaca fascicularis)
model of Parkinson's disease with and without de novo or
long-term L-DOPA treatment. The group with long-term
L-DOPA treatment displayed dyskinetic symptoms. We
examine the ability of eight normalization methods to
remove the intensity and spatial bias found in our data
produced with 2D-DIGE. Four of the methods have previ-
ously been used for data generated from 2D-DIGE and
four of them are novel. We also discuss existing methods
for producing cut-off levels for finding differentially
expressed spots/proteins and propose an alternative
method based on permutation tests. Finally we use the
method proposed in this study, DEPPS, to provide
insights on the priming effects of L-DOPA in the striatum
in parkinsonian animals.
Results
We have used 2D-DIGE to study the difference in protein
expression in the striatum of 27 animals which received
four different administration regimens. Six of the animals
were used as controls (Ctl), five were administered MPTP
only (Mptp), six animals were administered MPTP and
then a single dose of L-DOPA (Ldopa) and ten animals
were first administered MPTP then long-term treatment
with L-DOPA until displaying dyskinesia (Dysk). One of
the control samples were used twice, resulting in a total of
28 samples which were compared on 14 2D-DIGE gels.
All gel images were analyzed using the DeCyder software
v5.02 (GE Healthcare). On average 1126 ± 64 (standard
error of mean) spots were identified on the gels. As gel
number four displayed the most spots (1851), it was des-
ignated as the master gel for matching purposes. For eval-
uating the different normalization methods, we included
spots from each gel that were also found in the master gel.
When comparing the four experimental groups we only
included spots for which we had enough observations to
estimate all possible comparisons between treatment
groups, and for which the degrees of freedom in the linear
model were at least eleven. The quality of all these spots
was examined manually and subsequently 1211 spots
were used in the parameter estimation.
Evaluation of bias removal by different normalization 
methods
We have studied eight different normalization methods.
Two of the methods are provided with the DeCyder soft-
ware ('DeCyder no pool' and 'DeCyder pool'), two have
been published earlier in the literature ('Fodor' and
'Kreil') [9,10], two are known from two-channel cDNA
expression array data but have now been adapted to suit
2D-DIGE data ('loess+scale' and '2D loess+scale') and the
final two are a separate channel analysis approach that
have not been used on 2D-DIGE data before ('SC-quan-
tile' and 'SC-2D+quantile'). For comparison, we have also
included un-normalized data (raw data).
When the raw data was analyzed using only Cy5 and Cy3
intensities, significant dye bias was found in several of the
gels (Figure 1A). This dye bias was intensity dependant in
some of the gels (Figure 2A). Each of the 14 gels exhibited
spatial bias, irrespective of the treatment group identity of
the samples. For instance, in the top right corner of gel
four there were generally higher Cy3 intensities compared
to Cy5. The same applied for the higher mass regions
(top) of gel twelve (Figure 3A).
The 'DeCyder no pool' successfully removed dye-specific
differences (Figure 1B&2B). The same applied to the
'Loess+scale' method (data not shown and Figure 2F). The
'Kreil' method introduced bias in the lower intensity range
in some of the gels (Figure 2E, gel 4). However, none of
three methods removed the spatial bias seen in the raw
data (Figure 3B,E &3F).
Two of the pool-based normalization methods ('DeCyder
pool' and 'Fodor') removed the dye-specific differences,
but spatial bias remained (Figure 1C&1D and Figure
3C&3D). Because the Cy5/Cy3 logratios are calculated via
the pool channel (Cy2) the spatial pattern is different
compared to the methods not using the pool.
Comparing the two normalization methods included in
the DeCyder software ('DeCyder pool' and 'DeCyder no
pool') where the fold changes are calculated with or with-
out the pool channel (Cy2), the variability is larger when
the pool channel is included (Figure 2B&2C). This is a
natural consequence when two signals (Cy3 and Cy5) are
compared via a third signal (Cy2) rather than directly. The
two methods using the pool channel, 'DeCyder pool' and
'Fodor', produced the largest variability in fold changesBMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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Boxplots of M or m values Figure 1
Boxplots of M or m values. Boxplots of the M or m-values for the 14 gels (A) before, and (B-E) after normalization using dif-
ferent methods. Gels are ordered (1–14) according to the experimental design in Table 1. For method A, B and E the M-values 
are calculated as log2Cy5/Cy3 and for method C and D the m-values are calculated as log2Cy5/Cy2 and log2Cy3/Cy2. For method 
C and D this results in two boxplots for each gel. After optimal normalization the M or m-values should average to zero and 
have approximately the same variance (equally high boxes) in all gels. The methods which are not illustrated in the figure show 
an impeccable pattern similar to that of (E).
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MA plots for gel 4 and 12 Figure 2
MA plots for gel 4 and 12. MA plots for gel 4 and 12 (A) before, and (B-E) after normalization using different methods. The 
average log2 intensity, A, is calculated as (log2Cy5+log2Cy3)/2. For method A, B, E, F and G the M-values are calculated as 
log2Cy5/Cy3 and for method C and D the M-values are calculated as log2(Cy5/Cy2)/(Cy3/Cy2). The red line in each plot shows 
the Lowess smoothing of the entire data in the plot and should ideally be a straight line on zero. The method by Kreil et al [10] 
gives intensity dependant bias in the low range in gel 4 and when the M values are calculated via the pool channel (Cy2, method 
C and D) the data tend to be more variable.
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2D-M plot for gel 4 and 12 Figure 3
2D-M plot for gel 4 and 12. Spatial gel plots for gel 4 and 12 (A) before, and (B-E) after normalization using different meth-
ods. A reconstructed gel image with increasing isoelectric point (pI) (left-right) and decreasing protein mass (top-down). For 
method A, B, E, F and G the M-values are calculated as log2Cy5/Cy3 and for method C and D the M-values are calculated as 
log2(Cy5/Cy2)/(Cy3/Cy2). The ten percent highest and lowest M-values in each gel are color coded red and blue respectively. 
For several of the normalization methods the spatial bias remains.
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compared to all other methods, including the raw data as
can be seen in Figure 2C&2D.
When using the proposed '2D loess+scale' method the
spatial and intensity dependant dye bias were successfully
removed (Figure 2G&3G). From this observation we sug-
gest that the intensity dependant bias often found in 2D-
DIGE data may be completely or partly dependant on spa-
tial bias. To adjust the scales of the logratio distributions
the 2D loess adjustment was followed by between gel
scale normalization (Figure 1E).
In the single channel analysis, each of the three channels
on the 14 gels had different mean intensity but the vari-
ance of the data was quite similar, as can be seen by the
width of the boxes in Figure 4. Quantile normalization
('SC-quantile') forces each of the channels to have the
same mean intensity and range, but the spatial bias is sim-
ilar to that seen in raw data (Figure 4&5).
For the method 'SC-2D+quantile' when spatial location
normalization is applied to each of the three intensity
channels, the spatial bias is removed, but there are still
differences between the intensity means, therefore quan-
tile normalization is also applied (Figure 4&5).
Importantly the values of extreme observations are very
similar for raw data and data after spatial location normal-
ization (both for the two and three dye normalization
methods). These extreme values may represent true bio-
logical differences between samples and should therefore
only be slightly affected by the normalization (Figure
2&6).
Effects of different normalizations
All normalization methods gave different results for the
estimated spot expression differences between treatment
groups.
After normalization the spots were ranked and plotted in
a volcano plot. A volcano plot displays the measure of sta-
tistical significance of the change, lodsratio (for log-odds
ratio) versus the fold changes. A high lodsratio indicates a
higher chance of true differential expression compared to
a low lodsratio (see also Methods: Parameter estimation).
This method is widely used on data generated from gene
expression arrays [5,6] and occasionally on 2D-DIGE data
[13]. We calculated the lodsratios using the eBayes func-
tion in the Limma [6] R [18] package.
Figure 7 displays volcano plots comparing the experimen-
tal groups Mptp and Ctl (MvC) (see Methods: Parameter
estimation) based on the method 'DeCyder pool' (which
requires the use of the pool channel in the estimate of
each Cy5 and Cy3 value, and assumes the two estimates to
be independent) and 'SC-2D+quantile' (which requires
the use of the pool channel in the linear model and
assumes the three intensities from each gel to be corre-
lated). Several spots showed similar results with both
methods; the highlighted spots indexed 871 and 1572
both had high lodsratios compared to the rest of the spots.
Several spots such as 725, 748, 1491 and 1316 showed
minor differences in rankings and estimates. However
there were also several spots such as 1530 and 1629 with
very different rankings and effect estimates.
The standard errors of the spot expression estimates are
generally larger using the 'DeCyder pool' normalization
compared to the 'SC-2D+quantile' method. This is indi-
cated by the width of the 'DeCyder pool' volcano plot
compared to that of 'SC-2D+quantile' (Figure 7).
Although we can not prove which method provides the
most accurate results for each particular spot, reduced
standard errors of the spot expression estimates generally
gives better results.
The treatment effects and rankings could have been esti-
mated only using the Cy5 and Cy3 intensities (normalize
data using '2D loess+scale' method) and the pool channel
would have been excluded. In this study, where the effects
of all four treatments were compared with each other and
the original design was fairly skewed, the analysis gained
by including the pool channel (normalize data using 'SC-
2D+quantile' method), especially for those treatments
with few or no direct comparisons. See also Discussion;
The pool channel and parameter estimation.
Protein classification
Before any comparisons were made between the different
treatments, 317 spots were picked for identification. Of
these, 252 proteins were successfully identified. Based on
the criterions described above (see also Methods: Param-
eter estimation) the level of 231 proteins had been com-
pared between the four experimental groups. For the set
tests (see below) ten proteins were excluded from the
analysis due to limited information available on biologi-
cal function. The remaining 221 proteins were success-
fully classified into groups (sets) based on molecular
function, their membership in protein families, involve-
ment in biological processes and cellular localization. A
total of 47 sets were identified.
Results of parameter estimation and single differentially 
expressed spots
Using the 'SC-2D+quantile' normalization and least
squares estimates we calculated lodsratios for six contrasts
of interest (see Methods: Parameter estimation). Figure 8
illustrates volcano plots of the comparisons between
Mptp and Ctl (MvC), Ldopa and Mptp (LvM), Dysk andBMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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Boxplots of intensity values Figure 4
Boxplots of intensity values. Boxplots of the log2 intensity values for the 14 gels before and after normalization using differ-
ent methods. Red boxes (1–14) are Cy5, green boxes (15–28) are Cy3 and yellow boxes (29–42) are Cy2 intensities. The data 
for each dye is ordered gel 1–14. After optimal normalization the intensity values should have approximately the same average 
and empirical distribution (equally high boxes) in all gels.
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2D-Intensity plots for gel 4 and 12 Figure 5
2D-Intensity plots for gel 4 and 12. Spatial gel plots of Cy5, Cy3 and Cy2 intensities versus the average intensity for gel 4 
and 12 before, and after normalization using different methods. Each MCy5, MCy3 and MCy2 -spot value are calculated as the 
Cy5, Cy3 or Cy2-value divided by the average intensity I, (log2Cy5+ log2Cy3+ log2Cy2)/3. A reconstructed gel image for gel 4 and 
12 with increasing pI (left-right) and decreasing protein mass (top-down). The ten percent highest and lowest (MCy5, MCy3 and 
MCy2) -spot values in each gel are color coded red and blue respectively. There is a significant spatial bias in the raw data and 
after 'SC-quantile' normalization, which is removed using the 'SC-2D+quantile' method.
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3Dyes-I plots for gel 4 and 12 Figure 6
3Dyes-I plots for gel 4 and 12. 3Dyes-I plots for gel 4 and 12 before and after normalization using different methods. Each 
MCy5, MCy3 and MCy2 -spot value are calculated as the Cy5, Cy3 or Cy2-value divided by the average intensity I, (log2Cy5+ 
log2Cy3+ log2Cy2)/3. The red line in each plot shows the Lowess smoothing of the entire data in the plot and should ideally be 
a straight line on zero. Both the 'SC-quantile' and 'SC-2D+quantile' methods remove intensity dependant bias. The values for 
extreme observations are more or less unaffected after spatial loess normalization.
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Ldopa (DvL), Dysk and Ctl (DvC), Dysk and Mptp (DvM)
as well as that between Ldopa and Ctl (LvC).
Using a permutation test we estimated three lodsratio cut-
offs for each comparison, corresponding to FDR* 0.3, 0.5
and the minimum observed FDR*. Using a FDR* value of
0.3 for all comparisons resulted in 203 unique spots
above the lodsratios cut-offs whereas 57 of these spots
have been successfully identified and classified into sets.
Results of differential expression in predefined sets of 
proteins
The purpose in most 2D-DIGE gel experiments is to find
single proteins found to be differentially expressed
between e.g. two different treatments. However, we were
primarily interested in the expression changes of prede-
fined sets of proteins. It is anticipated that this also reduces
the number of false positive results, which is a risk when
looking at individual proteins on a large scale.
Based on the method presented by Subramanian et al [14]
and Tian et al [15] we calculated significance levels (p-val-
ues) for sets of proteins that show association with the pre-
defined phenotypes of interest.
The modified method used here, DEPPS, is based on rank-
ing (using the lodsratio) for all the spots in each set of
interest. An advantage with this kind of approach is that it
uses the whole ranking list of spots/proteins and not only
those above a certain lodsratio cut-off and/or fold change.
A p-value for each protein set was assessed by comparing
the result from the true comparison to those from the per-
mutations of gel numbers (10 000 permutations), (see
Methods; Differential expression in predefined sets of
proteins).
There were differences in the average level of the p-values
for the comparisons examined. Therefore it may not be
appropriate to use the same cut-off p-value across compar-
isons. Instead an alternative method using a quantile-
quantile -plot (qq-plot) with standardized p-values versus
the standard deviations of the p-values for each protein set
was used (Figure 9). Based on visual inspection of the
results for all comparison we selected the same relative
cut-off level (-0.9 ×standard deviation, S.d.) across the six
comparisons.
Volcano plots comparing 'DeCyder pool' and'SC-2D+quantile' Figure 7
Volcano plots comparing 'DeCyder pool' and'SC-2D+quantile'. Volcano plots showing the lodsratio and M-values for 
the MvC estimate using the two different normalization methods 'DeCyder pool' and the 'SC-2D+quantile'. There are several 
spots with similar ranking, but there are also spots with great differences in the lodsratio ranking and M-values.
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Protein sets
We wanted to explore if the method used herein (DEPPS)
can provide insights into the priming effects of L-DOPA in
the striatum of a parkinsonian animal model.
Four of the sets identified in the LvM comparison (Figure
9) were sets of proteins that are involved in energy metab-
olism or tubulin cytoskeleton. We will briefly discuss the
possible involvements of these four sets of proteins in rela-
tion to the priming effects of L-DOPA. The main biologi-
cal aspects of this study will be published separately
(manuscript in preparation).
Example I: Energy metabolism
Three sets of proteins involved in energy metabolism (gly-
colysis (G), tricarboxylic acid cycle (TCA) and alcohol
metabolism (AM)) were affected in parkinsonian animals
compared to single and long-term L-DOPA treatments
(Figure 9, LvM  and DvM and Figure 10). It should be
noted that there is a great overlap for proteins classified
into the sets for glycolysis and alcohol metabolism. For
proteins involved in alcohol metabolism, this difference
is also maintained after long-term L-DOPA treatment,
compared to untreated animals (Figure 9, DvC). There is
no common expression pattern for these sets of proteins,
which is not surprising since the energy metabolism com-
prises many complex pathways (Figure 12).
The changed state of proteins associated with energy
metabolism is encouraging since Crossman and co-work-
ers [19] analyzed 2-deoxyglucose accumulation and
reported metabolic changes in the basal ganglia in MPTP
and L-DOPA treated macaques, with the exception of the
striatum which was not studied. Other studies have
reported an increase of lactate in the striatum of parkinso-
nian models, indicating anaerobic glycolysis [20,21]. Met-
abolic pathways are known to be affected in several
Volcano plots for six comparisons of interest Figure 8
Volcano plots for six comparisons of interest. Volcano plots showing the lodsratios versus the effect estimates for six 
comparisons of interest. Cut-off levels in the lodsratio corresponding to FDR* equal to 0.30 (red), 0.50 (blue) and the minimum 
observed FDR* (dashed green) are plotted in each volcano plot.
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QQ plots of the standardized p-values versus the standard deviation across comparisons for each protein set Figure 9
QQ plots of the standardized p-values versus the standard deviation across comparisons for each protein set. 
For each of the six comparisons of interest a regression line is added which is based on the standardized p-values values 
between the first and third quartile. To assess which proteins sets that were different between comparisons we applied the 
same relative cut-off value of -0.9 (× S.d.) for all comparisons (black horizontal line). The three sets of proteins associated to 
energy metabolism (glycolysis (G), alcohol metabolism (AM) and tricarboxylic acid cycle (TCA)) were different in parkinsonian 
animals compared to L-DOPA treated parkinsonian animals (LvM). The closely related proteins sets for alpha and beta tubulins 
display different response for the LvM comparison.(Sets of: G = grey square, AM = green and black diamond, TCA = red solid 
circle, alpha tubulins = yellow triangle point-up, beta tubulin = blue triangle point down,)
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neurodegenerative disorders, for a review of recent pro-
teomic findings see [22].
Example II: Tubulin cytoskeleton
Proteins that form part of the microtubule cytoskeleton in
striatal tissue appear in this study to be affected by single
and long-term L-DOPA administration to parkinsonian
animals (Figure 9, LvM and DvM and Figure 11).
The actual difference in protein expression is low, but the
protein expression pattern is similar for most proteins in
the  set  (Figure 12). The alpha tubulins are expressed/
present to a lower level in parkinsonian animals (Mptp)
compared to untreated (Ctl), which appear to be reversed
after L-DOPA treatment (Ldopa). In contrast to alpha
tubulins, beta tubulins do not appear to be affected (Fig-
ure 9). The difference in biological response between
alpha and beta tubulins suggests different functions.
Dysfunctions of the neuronal cytoskeleton, especially the
microtubule system, have been associated with several
neurodegenerative diseases such as Alzheimer disease and
Amyotrophic Lateral Sclerosis (ALS) [23,24]. Further-
more, MPTP and its metabolites destabilize microtubules
[25]. This is interesting since dopaminergic neurons are
particularly sensitive to microtubule destabilizing agents
[26]. One other possibility is that dopamine regulates
changes in the striatal medium spiny neuron (MSN) den-
dritic trees and spines resulting in changes to the cytoskel-
eton. Dopamine depletion results in a reduction of spines
and synapses on striatal projection neurons [27]. Post-
mortem samples from Parkinson's patients also show
Volcano plots for proteins involved in energy metabolism Figure 10
Volcano plots for proteins involved in energy metabolism. Proteins involved in G and AM are color coded red 
(squares) and TCA are color coded blue (triangles). Cut-off levels in the lodsratio corresponding to FDR* equal to 0.30 (red) is 
plotted for all comparisons. For the LvM and DvM there is an 'enrichment' of G and AM proteins with higher lodsratios com-
pared to e.g. the DvL comparison.
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reductions in MSN dendritic spines and dendritic tree size
[28]. However, we do not know if the microtubule
changes seen in the striatum after L-DOPA treatment in
this study are based in dopaminergic fibers from the sub-
stantia nigra or in striatal medium spiny neurons and/or
interneurons.
Discussion
Normalization and spot matching
In the field of cDNA microarrays, spatial and intensity
effects arising from printing, hybridization, scanning and
other technical factors are known to mask the data
obtained from gene expression.
The same applies for protein studies using 2D-DIGE,
although the bias arises from different sources. Recent
studies by Fodor [9] and Kreil [10] have shown the need
for proper normalization and the need for development
of better normalization techniques.
Comparing the results by Kreil [10] to ours, their biologi-
cal example had more dye-bias, however they also
included more spots with low spot volume and there is
more dye bias in spots with low spot volume. We had a
low number of spots per gel with a low spot volume
(<40000), on average less than 2%. The differences com-
pared to the study by Kreil may be due to different biolog-
ical samples, the pH interval for the gel strips, the gel
concentration, the settings during scanning or a different
setting in the DeCyder software for spot detection.
The fact that we have generally fewer low-volume spots in
our data can also be explained by us having manually
checked the matching for all spots between the gels in the
multi gel interface in the DeCyder software (also known
as BVA, Biological Variance Analysis). In our experience
the automatic matching needs to be extensively checked,
since it is not uncommon with bad matching between
spots in different gels, and low volume spots are often sur-
Volcano plots for proteins involved in tubulin cytoskeleton Figure 11
Volcano plots for proteins involved in tubulin cytoskeleton. Proteins involved in Alpha and Beta tubulins are color 
coded red (squares) and blue (triangles). Cut-off levels in the lodsratio corresponding to FDR* equal to 0.30 (red) is plotted for 
all comparisons.
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rounded by other low volume spots, making the BVA
matching even more unreliable. A large gel set requires a
great deal of manual work to minimize the risk of bad
matching and it is often that low-volume spots fail to be
correctly matched, simply because they can not be found
with great confidence between gels.
The methods provided by Fodor [9] and Kreil [10] both
make use of the relationship between the dye-bias and
intensity but independently of spot location. We think
there is a risk of masking the true signals using 2D-DIGE
due to spatial bias. The '2D loess+scale' and 'SC-
2D+quantile' methods proposed in this report are two
new methods that remove both the intensity and spatial
bias found in 2D-DIGE data.
In cDNA microarrays the probes are often spotted in a ran-
dom manner across the microarray, so no spatial bias may
be expected. However using 2D-DIGE, spatial bias may to
some extent be expected. Certain proteins may be identi-
fied in the spot maps as tight rows of spots of proteins
originating from the same gene-product (PTMs). They
appear in rows in the gels because they have approxi-
mately the same mass but different charge.
The spatial bias we found in the raw data and in several
normalization methods showed that large areas of spots
had higher intensities with either Cy3 or Cy5, irrespective
of the treatment group identity of the samples. However,
in a case where two very different protein samples are
compared on the same gel, then the assumptions made
for normalization may not be valid. It can therefore be
very helpful to study the spatial plots of un-normalized
data, especially if both technical and biological replica-
tion is available. See also [29] for further discussions
about spatial trends in gel based data.
There are several sources that may cause the spatial bias,
such as variations in the quality of the gels, the labeling
efficiency of the dyes, incomplete number of proteins
transferred from the first to the second dimension and the
scanning procedure. It is also known that background
subtraction may introduce bias [30]. The procedure for
background subtraction using the DeCyder software is to
subtract the lowest tenth percentile of the pixel values on
the spot border. We have not been able to evaluate the
impact of this on the data, since it is not possible to disen-
gage background subtraction using the DeCyder software.
See also [31] for a review on sources of variation in gel-
based proteomics.
It is unclear from the present study which normalization
method gives the most accurate results for each particular
protein. However, in most cases the data used to find dif-
ferentially expressed proteins should not be intensity or
spatially biased. The '2D loess+scale' and 'SC-2D+quan-
tile' methods proposed in this study are the only methods
that sufficiently satisfy these two criteria.
Loess smoothing and possible software improvements
When using loess smoothing [32], the smoothing factor
has to be set by the user. This factor (also known as span)
indicates the percentage of spots to be used in the estima-
tion of each point of the loess curve.
Profiles for proteins involved in energy metabolism and alpha tubulins Figure 12
Profiles for proteins involved in energy metabolism and alpha tubulins. Profiles showing the effect on proteins 
involved in energy metabolism and alpha tubulins in parkinsonian animals (Mptp), after one de novo L-DOPA dose (Ldopa) and 
after long-term L-DOPA treatment resulting in dyskinesia (Dysk). The expression changes are relative the control animals 
(Ctl). G profiles are proteins involved in glycolysis, AM for proteins involved in alcohol metabolism and TCA profiles are pro-
teins involved in the citric acid cycle.
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For the master gel (gel 4) a smoothing factor between 0.05
and 0.1 satisfyingly removed both the intensity and spa-
tial bias. Using the same smoothing factor on a gel with
only half as many spots, the estimation of each point
would be performed on relatively fewer spots and there
may be a risk of over fitting. To minimize the risk of over
fitting a smoothing factor proportional to the number of
spots is appropriate. In this case a factor of e.g. 100/
[number of spots], gives a higher span for gels with less
spots. This may seem as a relative low smoothing factor,
but the spatial bias found in our gels are relative local. A
smoothing factor that is too high would result in a more
global intensity biased normalization rather than local
bias normalization.
For ideal 2D-DIGE spatial (and global) normalization all
spots identified in each gel should be used for normaliza-
tion, instead of only using spots also found in the master
image. This would probably improve the local bias nor-
malization slightly and therefore give a better final result.
Using version 5.02 of the DeCyder software this is not
possible because the merging of two spots in the multi-gel
comparison interface, BVA, results in no update of the
original spot map. Consequently the normalized value
can not be extracted. If no spots in any of the gels have
been merged it is possible to use all spots, but in our expe-
rience this is seldom the case.
The pool channel and parameter estimation
The DeCyder software manual, as well as Fodor et al [9],
recommends the pool channel (Cy2) to be used in the sta-
tistical analysis for all types of gel experiments.
After normalization ('DeCyder pool' and 'Fodor'), the
pool channel intensity will generally not cancel out when
the logratios are combined, but there will be an error term
connected to each of log2Cy5/Cy2 and log2Cy3/Cy2. Karp
et al [33] even suggests that the Cy2 channel gives more
noise than each of Cy3 and Cy5, in which case the noise
added in each step of log2Cy5/Cy2  and log2Cy3/Cy2
would be higher than the single noise term in the direct
measurement log2Cy5/Cy3.
The linear model is then based on the logratios log2Cy5/
Cy2 and log2Cy3/Cy2 rather than directly on the logratios
between the red and the green intensities (log2Cy5/Cy3)
only or on the log intensities log2Cy2, log2Cy3  and
log2Cy5. According to the DeCyder software manual, as
well as Fodor et al [9], these logratios may be considered
as independent measurements.
We want to stress that if a log difference between only two
samples on the same gel is to be measured, the standard
error of the measurement will be larger if the difference is
estimated via a third (pool) sample than if it is estimated
directly between the samples of interest. Additionally the
logratios log2Cy5/Cy2 and log2Cy3/Cy2 can not be consid-
ered as independent measurements, since they originally
come from the same gel.
As a consequence, in a case where only two treatments are
compared with replicate gels, we advocate the use of the
pool channel (Cy2) for mapping between gels and the use
of normalized M-values (log2Cy5/Cy3) in the linear
model.
In a case where more than two treatments or states will be
compared the situation may be different, then the analysis
may improve on including the pool channel in the linear
model. We recommend the data first be normalized using
'SC-2D+quantile' and then the three log2 intensity esti-
mates for each spot on a gel should be treated as corre-
lated observations. As a consequence the three dyes
should be treated as fixed effects and the gels should be
treated as blocks by a random effect in the linear model.
Experiments should be carefully designed so that the com-
parisons of particular interest are made within gels rather
than between gels. The labeling using different dyes (espe-
cially Cy5 and Cy3 if Cy2 is used for the pool samples) of
the experimental groups should also be balanced. Since
our experiment was originally designed following only
the manual of the DeCyder software (which then assumed
no dye bias), little attention were given to the possibility
of systematic bias within the experiment and the balance
of the dyes for each experimental group in the design.
See also microarray statistics theory on direct versus indi-
rect experimental designs in e.g. [34,35]
Protein identification and predefined sets of proteins
Traditionally, studies of gene expression have drawn bio-
logical conclusions from lists of differentially expressed
genes. The development and use of a more pathway-ori-
ented approach in gene studies, such as GSEA[14], have
recently become more popular.
Most 2D-DIGE studies have focused on identifying indi-
vidual spots (proteins) that are differentially expressed
between two states. Using this approach it is hard to make
conclusive remarks about effects in biological processes
and pathways.
We have used a pathway orientated approach (DEPPS) in
this 2D-DIGE study. The ideal situation would have been
to have all spots in the gels identified, but this is quite dif-
ficult, especially for the low volume spots. There are sev-
eral reasons for our relative low number of identified
spots with low spot volume. The main reason is that the
spots were manually picked from preparative CoomassieBMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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stained gels (see Methods: Spot picking and digestion).
The Coomassie staining is less sensitive compared to the
CyDye staining. The lesser sensitivity can not be com-
pletely compensated for by loading more proteins on pre-
parative gels. Consequently spots with low spot-volumes
in the 2D-DIGE gels could not be found in the preparative
gels, at least not with a great certainty that they were the
same spots.
Another reason is that the spots were manually extracted
from the preparative gels in a random and unbiased way
before any statistical analyses were made. Spots that had
been picked for identification were afterwards matched to
the 2D-DIGE gels. It may have been possible to first find
the spots in the 2D-DIGE gels, then try to match these low
spot-volume proteins (between 2D-DIGE and preparative
gels) and then pool spots from several preparative gels to
get enough of protein for protein identification. This was
not done due to the extensive workload needed.
Although some interesting low-volume spots may have
been missed for protein identification, we think that look-
ing at differences between groups in sets of proteins has
revealed confirmatory and new intriguing results in an
animal model of Parkinson's disease. This is in spite of the
quantitatively small differences between the treatments.
These results would probably not have been found when
looking only at single differentially expressed proteins.
The false discovery rate (FDR) and significance levels
The issues of significance levels and multiple testing are
often revisited in the literature of gene expression, with
varying conclusions drawn. In 2D-DIGE gels, where loca-
tion and content of spots are unknown before the experi-
ment is carried out, the complexity is further increased
compared to gene arrays. A spot/protein originating from
the same gene-product may be represented in several posi-
tions in the gels due to PTMs and artifact spots may also
be present. Therefore the spots, and hence the tests, may
not be considered independent. As a consequence we give
little confidence in the determined significance levels or
false discovery rates.
To address this problem we derived potential lodsratios
cut-off for each comparison through a permutation test.
This test can be used as guidance for deriving cut-off lev-
els, especially for studies where only a limited number of
spots will be identified. However, we still prefer to see the
observed single spot lodsratios solely as rankings of the
evidence for changes in protein activity. To detect changes
in biological processes for known and well characterized
proteins we recommend using methods such as DEPPS
which makes use of the whole ranking list.
Conclusion
This study demonstrates that there may be substantial
intensity and spatial bias in 2D-DIGE data. The '2D
loess+scale' and 'SC-2D+quantile' are the only normaliza-
tion methods evaluated in this study that sufficiently
remove both the intensity and spatial bias.
For direct comparison between two treatments or states
we recommend the use of normalized M-values and that
the commonly used pool channel (Cy2) should be used
for mapping between gels only.
When more than two treatments or states will be com-
pared the pool channel (Cy2) may be included in the lin-
ear model but this depends on the original study design
and comparisons of interest. The three log2 intensities of
the dyes should then be treated as correlated single chan-
nel fixed effects and the replicate gels should be treated as
a random factor in the linear model.
Different methods correcting the observed significance
levels are used for 2D-DIGE data. We like to stress that the
gel spots, and hence the tests, can not be considered as
independent measurements. As a consequence we recom-
mend the p-values in significance tests in 2D-DIGE data to
be used as rankings only and that looking at sets of pro-
teins instead of individual proteins generates more accu-
rate and biologically informative results.
Using the DEPPS method which is based on sets of pro-
teins; we found that proteins in the striatum that are
involved in energy metabolism and tubulin cytoskeleton
appear to be affected by the administration of L-DOPA in
the golden-standard animal model of Parkinson's disease.
Methods
Animal treatment
All animal studies were carried out as described in [36] in
accordance with European Communities Council Direc-
tive of 24 November 1986 (86/609/EEC) for the care of
laboratory animals. A total of 27 female monkeys (Macaca
fascicularis, SAH, Beijing, China; average age = 4.4 years
(between 4–7 years); mean weight = 2.9 kg (2.4–3.4 kg))
were used and rendered parkinsonian and dyskinetic
according to published methods [19,37-41]. Six animals
were kept as a control group and the remaining 21 ani-
mals were injected with MPTP hydrochloride until bilat-
eral parkinsonian symptoms of comparable severity were
stabilized (mean cumulative dose of 2.44 mg/kg). Ten
animals were dosed with L-DOPA (Modopar®, Roche, L-
DOPA/carbidopa, ratio 4:1) twice daily (approximately
for 4.5 months). The L-DOPA dose was tailored to pro-
duce a full reversal of the parkinsonian condition (20–60
mg). All ten animals exhibited L-DOPA induced dyski-
nesia and received their final tailored dose of L-DOPA oneBMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
Page 19 of 27
(page number not for citation purposes)
hour before death. Eleven animals were kept without L-
DOPA administration for approximately 4.5 months. Six
of these animals received a single dose of L-DOPA (50
mg) one hour before death. All animals were killed with a
sodium pentobarbital overdose (150 mg/kg, i.v.). Dissec-
tion of different brain regions were performed on ice with
the brain immersed in cold saline (0.9%) in less than 15
min. The striatum (combining caudate nucleus, putamen
and nucleus accumbens, across the rostrocaudal extent of
the structure) was dissected from each hemisphere, imme-
diately frozen at -45°C in isopentane and then stored at -
80°C.
Sample preparation
Each frozen striatum was taken directly from the freezer,
put in an eppendorf-tube, and rapidly homogenized in a
4:1 (v/w) ratio of lysis buffer containing 8 M urea, 4% 3-
[(3-Cholamidopropyl)Dimethyl-Ammonio]-1-Pro-
panesulfonate (CHAPS), 70 mM dithiothreitol (DTT), 5%
immobilized pH gradient (IPG) buffer pH 3–10, using a
sonicator. The sonication was performed on ice (to avoid
carbamylation of the proteins) in pulses for 10 seconds
(Fisher Bioblock scientific), followed by ultracentrifuga-
tion for 1 hour at 100 000 × g (Beckman Optima, Beck-
man). Supernatants were collected and cleaned from
lipids and nucleic acids using the 2D Clean-up Kit (GE
Healthcare, Uppsala, Sweden), according to the manufac-
turer's instructions. The total protein concentration of
each sample was determined using the 2D Quant Kit (GE
Healthcare) in accordance with the manufacturer's proto-
col. The whole procedure was performed on ice whenever
possible to minimize protease activity.
Design
This study consists of 14 2D-DIGE gels. Each gel contains
two striatum samples from different animals. The samples
have either been labeled with the red (Cy5) or the green
(Cy3) fluorescent dye. Additionally, all gels contain a
third sample which is a pool of all the samples in the
experiment. Equal amounts of proteins from each of the
individual sample were used for the pool. This pool sam-
ple is labeled with the yellow (Cy2) fluorescent dye and
plays an important role in the matching of spots between
gels. It is also included in some of the normalization
methods evaluated in this paper and in some of the statis-
tical methods for parameter estimation.
The experimental design (the distribution of the samples
between gels) is tabulated in Table 1. All the Cy5 and Cy3
labeled samples are biological replicates but one; the Cy5
labeled sample used on gel 14 is a technical replicate of
the control animal, which is also represented on gel 4. The
technical replicate was not treated differently from the
biological replicates, since we believe the gains would be
marginal in the otherwise so complex system. The gels
were run six at a time and the final two last.
Gel preparation
For 2D-DIGE we labeled 50 µg each of control, treated,
and pooled protein sample with cyanine dye Cy5 or Cy3
and Cy2, respectively, according to the manufacturer's
descriptions for CyDye DIGE Fluor minimal dyes (GE
Healthcare). The pooled sample was a mixture of equal
amounts of protein from all samples in the experiment.
Before the first-dimension isoelectric focusing (IEF), a 50-
µg aliquot from each of the three labeling mixes (see
above) was combined with DeStreak rehydration buffer
and 0.5% (v/v) Pharmalytes (GE Healthcare) that covered
the pH interval (pH 3–11 NL) of the IPG strips, to give a
final volume of 450 µL.
Gel rehydration of the 24-cm IPG strips (GE Healthcare)
with the 450-µL rehydration buffer (including the protein
sample), was performed at room temperature in the dark
for 12 hr according to the manufacturer's instructions. IEF
was run on an IPGPhor (GE Healthcare) at 500 V for 1 hr,
at 1 kV for 1 hr, and at 8 kV until a total of 64 kVh was
reached. After IEF, the strips were equilibrated for 2 × 15
min by gentle shaking in a buffer containing 50 mM Tris-
HCl (pH 6.8), 6 M urea, and 2% sodium dodecyl sulfate
(SDS), supplemented with 2% DTT in the first equilibra-
tion step and 2.5% iodoacetamide in the second. For the
second dimension SDS-polyacrylamide gel electrophore-
sis (SDS-PAGE), the equilibrated strips were put on top of
large format 12.5% polyacrylamide gels and were run
Table 1: 2D-DIGE experimental design
Gel Cy3 Cy5
1C t l 1 L d o p a 2
2 Ctl2 Dysk5
3C t l 3 C t l 4
4C t l 5 M p t p 1
5C t l 6 M p t p 3
6 Mptp2 Ldopa4
7 Mptp4 Dysk10
8M p t p 5 D y s k 1
9 Ldopa1 Dysk6
10 Ldopa3 Dysk9
11 Ldopa5 Dysk2
12 Ldopa6 Dysk7
13 Dysk3 Dysk8
14 Dysk4 Ctl5
Each gel had three samples. Two corresponding to a sample of 
interest (labeled with Cy3 or Cy5) and a pooled standard which is a 
mix of all samples used in the study (labeled with Cy2). The samples 
were from four different groups of animals: untreated animals (Ctl), 
those treated with Mptp (Mptp), those treated with Mptp plus one 
acute dose of L-DOPA (Ldopa) and finally those treated with Mptp 
and long-term L-DOPA treatment (Dysk).BMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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using an Ettan DALTsix large-format vertical system (GE
Healthcare). The gels were run at 5 W for 45 min before
increasing to 11 W per gel until the bromophenol blue
dye front had reached the bottom of the gel. The temper-
ature was kept constant at 27°C. The gels were then sub-
jected to image analysis.
Scanning and image analysis
All gels were scanned using a Typhoon 9400 (GE Health-
care) at 100 µm resolution. The images were analyzed
using the DeCyder software suite (GE Healthcare, version
5.02). All 14 × 3 images were loaded into the DeCyder
Batch processor, and the program was set to find 3000
spots in each image then filter away artifacts and finally to
do a primary matching between all the different gel
images. The resulting files were then loaded into the BVA
module for further image analysis.
All spots were manually compared between the different
gels to minimize false spot matching. The gel with the
largest number of spots identified was used as the master
gel. When needed, spots were merged to better match
against the spots in the master gel. Volume data, DeCyder
normalized data, and coordinate data for each spot was
exported using the DeCyder XML toolbox.
Spot picking and digestion
Preparative gels containing 500 µg proteins were stained
with Colloidal Coomassie Brilliant Blue G (Acros Organ-
ics, Geel, Belgium) and matched to the fluorescent 2D-
DIGE images. Spots were manually extracted from a total
of six preparative gels (n = 6). As many spots as possible
recognizable in both 2D-DIGE and preparative gels were
extracted. Gel pieces (spots) were washed twice (0.2 M
NH4HCO3/50% ACN) with 30 min incubation at 30°C.
Subsequently, the gel pieces were dried by SpeedVac con-
centration (Concentrator 5301, Eppendorf) and trypsi-
nated (0.4 µg trypsin/gel piece (Modified Sequence Grade
Trypsin, Promega)) followed by overnight incubation in
30°C. Trypsin activity was stopped by addition of trifluor-
oacetic acid (TFA) to an final concentration of 1%. Pep-
tides were extracted with 60% ACN/0.1% TFA followed by
complete drying by SpeedVac to remove organic solvents.
The peptides were then re-suspended in 15 µl 0.25% Ace-
tic acid (HAc).
Protein identification
The tryptic digests from each spot were dissolved in 10 µl
0.25% (v/v) acetic acid. Five µl was desalted on a Nano-
Precolumn (LC Packings, Amsterdam, the Netherlands)
using Ettan MDLC (GE Healthcare). The digest was then
separated by a 20 minute gradient from 3 to 80% ace-
tonitrile in 0.25% acetic acid on a 15 cm, 75 µm inner
diameter C18 capillary column (LC Packings, Amsterdam,
the Netherlands). At a flow rate of approximately 150 nl/
min the peptides were electro sprayed into a linear ion
trap mass spectrometer (LTQ, Thermo Electron, San Jose,
CA, USA). The spray voltage was 1.8 kV, ES source capil-
lary temperature was 160°C, and 35 units of collision
energy were used to obtain peptide fragmentation. One
zoom scan spectrum and one tandem mass spectrometry
(MS/MS) scan spectrum were collected in a data depend-
ent acquisition manner following each full-scan mass
spectrum. The dynamic exclusion feature enabled
sequence information of as many co-detected peptides as
possible.
The information from the electro spray ionization MS and
MS/MS spectra were correlated to protein and translated
DNA sequence data in the UniProt database using Mascot.
The non-redundant sub database of Homo sapiens was
used with the parameters as follows: partial oxidation of
methionine (+16 Da), and cysteine alkylation (+57 Da),
peptide mass tolerance of 1.5 Da and fragment ion mass
tolerance of 0.8 Da. Trypsin was specified as the digesting
enzyme with a maximum of one missed cleavage. The cri-
teria for positive identification of a protein were two or
more peptides with each a Mascot score of 33 or higher
from the same protein. The full list of all identified pro-
teins and their peptide Mascot scores will be published
separately (manuscript in preparation).
Protein classification
All identified proteins were manually categorized using
the information, when available, provided by the Gene
Ontology project [42] and related information from the
scientific literature. The classifications of the proteins were
based on molecular function, their involvement in bio-
logical processes and/or cellular localization. The classifi-
cations were solely based on similarities in function and
biological processes of all the proteins as seen by the
authors. Literature references used in classifications that
are not solely based on Gene Ontology (GO) will be avail-
able in the biological interpretation of the data in this
study (manuscript in preparation). Based on the informa-
tion available on the identified proteins, 47 classes were
identified. A single protein may have been classified into
several different sets.
Methods for normalization
In the field of two channel cDNA microarrays, normaliza-
tion methods seek to ensure that systematic variation,
such as dye effect, are removed while biological variation
is retained.
After normalization the fluorescent dye intensities are
expected to be balanced, that is show equal amount of sig-
nal corresponding to equal gene expression levels. This
assumption is valid in cDNA microarrays only if a small
proportion of the spots (genes) are different betweenBMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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treatments, and if spots are printed in a random order on
the microarray slide.
For the normalization of data from 2D-DIGE we assume
that only a small proportion of the spots/proteins are dif-
ferent between treatments and that they do not appear in
a systematic spatial pattern (violations to this assumption
may in some cases be expected, though. See also Discus-
sion; Normalization). In this study we have evaluated
eight different normalization methods, whereas four of
them have not previously been used on 2D-DIGE data.
The DeCyder software (GE Healthcare) provides two
methods for data normalization. We call them 'DeCyder
no pool' and 'DeCyder pool' respectively. The 'DeCyder
no pool' method is recommended only when there is no
pool channel included in the experiment. The method
consists of channel specific shifts in log intensities (log
volumes), so that the distribution of log intensities gets
centered on zero for each dye channel. The 'DeCyder pool'
performs equivalent shifts on each of the two series of
logratios log Cy5/Cy2 and log Cy3/Cy2 from each gel.
Two different normalization strategies for 2D-DIGE data
have recently been suggested in Kreil et al [10] and Fodor
et al [9], we will name the methods 'Kreil' and 'Fodor'
respectively. Their strategies were first developed for the
normalization of two channel cDNA expression data.
'Kreil' do not include the pool channel. Variance stabiliza-
tion normalization (vsn) [4] is applied to each red (Cy5)
and green (Cy3) channel separately, followed by a median
shift [8] of the gel specific logratios log Cy5/Cy3  and
finally standardization of the logratio distributions of all
the gels to an equal scale by a robust Z-score.
'Fodor' first applies 'DeCyder pool' normalization but
then adjusts the gel specific 'standardized log abun-
dances', log Cy5/Cy2  and log Cy3/Cy2, for within gel
intensity dependence with a loess smoother [32], and
scales the resulting gel specific quantities (log Cy5/Cy2)'-
(log Cy3/Cy2)' to equal scales for the middle 50 percent of
these quantities for each gel [8].
We have also tested four normalization methods that
have not been used on 2D-DIGE data before. We call the
first two methods 'loess + scale' and '2D loess + scale'.
Yang et al [8] introduced the robust scatter plot smoother
loess [32], to adjust for intensity bias in two channel
cDNA microarray expression data. In two-channel spatial
loess normalization a loess smoother function is esti-
mated from the differences (M) between the (log2) dye
intensities, log2Cy5-log2Cy3. The estimated loess function
is then subtracted from the differences (M), and the sepa-
rate log2 intensities, log2Cy5 and log2Cy3 can be recov-
ered. In effect, the method comes down to shifting both of
the two sets of log-intensities (log2Cy5) and (log2Cy3) to
their average (log2Cy5+log2Cy3)/2, except noise and true
differential expression are still present. The scaling tech-
nique by Yang et al [8]which adjusts the scales of the
logratio distributions to equal levels between the microar-
ray slides, is seldom needed in microarray analysis, but we
see a more general need for such scaling between 2D-
DIGE gels, therefore we also perform scaling between gels.
For the 'loess + scale' normalization, we used the function
normalizeWithinArrays with default settings and normal-
izeBetweenArrays using 'scale' found in the software R
[18] Limma package [7].
The '2D loess + scale' is a spatial location normalization
method. The loess smoother function is now estimated
from the differences (M) between the (log2) dye intensi-
ties, log2Cy5-log2Cy3, as a 2-dimensional function of the
spot coordinates on the protein gel. The estimated loess
function is then subtracted from the differences (M). The
method eliminates the phenomenon of one dye showing
generally higher values than the other across regions of
the gel. For the loess smoother estimation we make use of
all of the spots that are also found in the master gel (see
also Discussion: Possible software improvements). For
the spatial location normalization we used the function
ma2D in the marray R package [3]. The coordinates for
each spot was extracted from the DeCyder software. The
smoothing factor was calculated as the ratio 100/[number
of spots also found in the master image] for each gel. The
data was finally scaled between the gels, as described
above.
The final two methods make use of the raw intensities for
all three dyes. The first method 'SC-quantile' (for Single
Channel quantile normalization) was developed for sin-
gle-channel Affymetrix data [43] and it ensures that the
intensities for the three dyes have the same empirical dis-
tribution across gels. The second method 'SC-2D+quan-
tile', first applies spatial location normalization and then
single channel quantile normalization.
To perform spatial normalization for the three dyes, we
extended the two channel loess methods described above
to suit three (or more) channels. We performed spatial
loess normalization with three dyes such that all the three
sets of log2-intensites from a spot (log2Cy5, log2Cy3 and
log2Cy2) were shifted to the average intensities (log2Cy5+
log2Cy3+ log2Cy2)/3, except noise and true differential
expression were kept. In practice this was done using the
ma2D function in the marray R package [3] three times.
Instead of the two sets of log2-intensites log2R and log2G,
we supplied one set of log2-intensities (log2Cy5 or log2Cy3
or log2Cy2) as well as the set of averages (log2Cy5+
log2Cy3+ log2Cy2)/3 to the function ma2D, so that theBMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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log2-intensites would be subtracted by the averages, and
the loess function fit to and subtracted from the resulting
differences. The normalized log2-intensites were then
derived by adding the averages (log2Cy5+ log2Cy3+
log2Cy2)/3 again to the output of the ma2D. The same
idea can be used to generalize loess normalization of
intensity bias to settings with more than three channels.
After loess normalization the single channel data was also
quantile normalized as described above.
We have used diagnostic plots to examine the raw data
and the ability of the different normalization methods to
remove intensity and/or spatial bias. We will normally
calculate M-values as log2Cy5/Cy3 but for method 'Fodor'
and 'DeCyder pool' which includes the pool channel
(Cy2) M will be calculated as log2(Cy5/Cy2)/(Cy3/Cy2).
We will consequently define m-values as log2(Cy5/Cy2) or
log2(Cy3/Cy2). The average log2 intensity (A) is calculated
as(log2Cy5+log2Cy3)/2.
To compare different methods we used box plots of M and
m-values, scatter plots of M versus A-values (MA plots)
and color coded spatial gel plots that depicts M-values and
the coordinates for each spot given in the DeCyder soft-
ware (2D-M plots).
For the single channel analysis we calculated three logra-
tios for each spot:
MCy5 = log2Cy5/I, MCy3 = log2Cy3/I and MCy2 = log2Cy2/
I, where
I = (log2Cy5+ log2Cy3+ log2Cy2)/3.
To compare methods for single channel analysis we used
box plots of all three log2 intensities, scatter plots of MCy5,
MCy3 and MCy2 versus I-values (3Dyes-I plots) and color
coded spatial gel plots that depicts MCy5,  MCy3  and
MCy2-values and the coordinates for each spot (2D-Inten-
sity plots).
Parameter estimation
Our interest was in comparing protein expression across
four distinct groups of target samples; striatum in the
basal ganglia from untreated animals (Ctl), from those
treated with MPTP (Mptp), striatum from those treated
with MPTP plus one acute dose of L-DOPA (Ldopa) and
striatum from those treated with MPTP and long-term L-
DOPA treatment (Dysk).
We were interested in six different comparisons; those
between Mptp and Ctl, Ldopa and Mptp, Dysk and Ldopa,
Dysk and Ctl, Dysk and Mptp and Ldopa and Ctl. We
called the corresponding parameters MvC, LvM, DvL, DvC,
DvM and LvC respectively, so that e.g. MvCp represented
the expected difference in expression levels between the
Mptp and Ctl treatment groups for protein p on a log2
scale.
For each spot/protein p, we based our statistical analysis
on the log2-intensites (log2Cy5p1,..., log2Cy5pJ  ,
log2Cy3p1,..., log2Cy3pJ , log2Cy2p1,..., log2Cy2pJ) where p =
1,..., P is a spot/protein index and j = 1,..., J is a gel index.
The gels were treated as blocks in the linear model, so that
effects were estimated within gels where possible. Hence a
mixed model was set up with gel as random factor (βj, j =
1,...,14), dye as fixed factor (Fk, k = 1,...,3) to account for
differences between the channels Cy5, Cy3 and Cy2 and
fixed effects T1,...,T4  for the four treatment states Ctl,
Mptp, Ldopa and Dysk. Let, for example, Zpjkl denote the
log2-intensity for the spot/protein p on gel j, channel k,
which happens to reflect an expression level under treat-
ment l. Then we let
Zpjkl = βj + Fk + Tl + εpjk,
where εpjk is an error term which we assume follows a nor-
mal distribution εpjk~ iid N(0, σ2
εp). We also assume that
βj follows a normal distribution, but with a different vari-
ance, βj~ iid N(0, σ2
βp). The pool channel samples, which
originally were created by taking equal amounts of pro-
teins from each sample and mixing, were consequently
assumed to contain 6/27 Ctl, 5/27 Mptp, 6/27 Ldopa and
10/27 Dysk.
After the data had been normalized using 'SC-2D+quan-
tile', the six comparisons (or effects) of interest were esti-
mated by the least squares method using the lmFit Limma
function [6]. The correlation between the spots of the
three dyes within each gel was first estimated using the
function dupcor [44] in Limma. To test for differences
between the expression levels in the treatment groups we
calculated lodsratios (Bpl) for each protein p and effect l for
the effects MvC,  LvM,  DvL,  DvC,  DvM  and  LvC  using
eBayes in Limma, (see [5,6]).
The eBayes function is a further development on the
method proposed by [5]. This empirical Bayes lodsratio or
equivalently smoothed (penalized) t-statistic [6] was first
developed for gene expression data and it is based on an
empirical Bayes estimate of the standard error. An increas-
ing differential expression (increasing M) increases the
lodsratio (for log-odds ratio) all the more if the variance
is small. However if M is small too, a factor in the model
ensures that the lodsratio cannot blow up due to small
variances. Using only the average M values as statistic for
differential expression some spots will be driven by out-
liers and using the ordinary t-statistic others will be
strongly influenced by small standard error estimates.BMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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Empirical Bayes statistics can rule out both of these cate-
gories of spots (genes or proteins).
It is important to include as many spots as possible, since
they add information about the distribution of (particu-
larly noise) expression level differences, which is needed
in the calculation of the lodsratios. However, we still rec-
ommend the spots between gels to be carefully mapped as
this minimizes the risk of including wrongly mapped
spots and non-sense data. The mapping of spots can be
very time-consuming, but in our experience this also low-
ers the number of hypothesis tests that later have to be
made. We included spots for which we had enough obser-
vations to estimate all possible comparisons between
treatment groups, and for which the degrees of freedom in
the linear model was at least eleven.
The full spot list was used to calculate lodsratios although
not all spots had been identified. We assume that small
spots behave vaguely like spots of proteins with low
expression levels. Although a crude assumption it is prob-
ably a good first approximation. For each comparison a
volcano plot was made, which shows the calculated lod-
sratios versus the parameter estimate, i.e. the magnitude
of the difference.
For the parameter estimation using 'DeCyder pool' nor-
malized data, the blocking effect (βj) was omitted and
only the dye effects for Cy5 and Cy3 were included.
Defining cut-off levels
The goal of most 2D-DIGE studies is to find single regu-
lated proteins between two different conditions, by test-
ing for significant variation between the means or
medians. We and others have then used methods for cor-
recting the significance levels, because numerous tests are
performed simultaneously [9,13]. However the issue of
multiple testing in 2D-DIGE, compared to microarrays, is
more complex to address. A protein originating from the
same gene product but with different modifications
(PTMs) may be represented in several positions in the
gels. Merging these spots into a single abundance would
possible cause a misinterpretation of the effect on protein
level. Since not all spots in the gels have been identified
there is also a risk of including data from artifact spots. In
summary it is probably not valid to assume the spots, and
hence the tests to be independent.
To address this problem we derived potential lodsratio
cut-offs for each comparison through the permutation test
described next.
A set of 10 000 non-sense datasets were produced by per-
muting the gel numbers in the real dataset. We then fol-
lowed the outline described earlier where spots were
excluded if there were not enough observations (see Meth-
ods; Parameter estimation), and derived the effect esti-
mates and the lodsratios for each dataset. For predefined
potential lodsratio cut-off levels in each contrast we regis-
tered the number of spots observed above the cut-off in
the non-sense datasets.
To adjust for differences in size between nonsense datasets
we multiplied these numbers by the number in the real
dataset (1211) and divided by the number of spots in
respective non-sense dataset. The resulting, adjusted num-
bers of spots above each specific cut-off was then averaged
(to n*, say) over the 10 000 non-sense datasets. The aver-
age was compared to the observed number of spots above
the cut-off in real data, say n. An estimate of the false dis-
covery rate connected to the cut-off was derived as FDR*
= n*/n.
For each contrast we calculated the lodsratio cut-off levels
for the FDR* of 0.30, 0.50 and the minimum observed
FDR*.
Differential expression in predefined sets of proteins
Single differentially expressed proteins and their interpre-
tation may be interesting as such, but studying each pro-
tein separately may be difficult and ineffective in many
cases. Instead we were primarily interested in the expres-
sion changes of predefined sets of proteins and their inter-
pretation.
In a paper on genome-wide expression by Subramanian et
al [14] a method is presented to determine whether mem-
bers of a predefined gene set S tend to show similar
degrees of differential expression. The authors developed
a non-parametric location test statistic, which is evaluated
through a permutation scheme where gene labels are per-
muted. They named their method Gene Set Enrichment
Analysis (GSEA).
Tian et al [15] point out that GSEA only tests the genes for
similar behavior, whether they show differential expres-
sion, non-differential expression or only vague but similar
results. Tian et al [15] divide the task into two null hypoth-
eses:
Q1: The genes in S show the same pattern of association
with the phenotype as the rest of the genes.
Q2: The gene set does not contain any genes whose expres-
sion levels are associated with the phenotype.
They suggest a test statistic which is the single gene test sta-
tistics averaged over the gene set, and test Q1 by permuting
gene labels (which correspond to our protein labels) andBMC Bioinformatics 2006, 7:475 http://www.biomedcentral.com/1471-2105/7/475
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Q2  by permuting array labels (corresponding to gel
labels).
Our interest is in groups of proteins for which any (possi-
bly few) proteins show association with the phenotype of
interest. The proteins in these sets do not necessarily have
to behave similarly, which would be tested by Q1. We
therefore test the Q2 hypothesis only.
Below we modify the method further and adapt it to pro-
tein data. We call our method DEPPS (Differential Expres-
sion in Predefined Proteins Sets).
For a protein set S, we calculate the test statistic
for each comparison i of interest, where Bpi is the lodsratio
score for protein p  and comparison i, and |S| is the
number of proteins in S. We compared   to 10000
equivalent non-sense statistics   which we
got by permuting gel numbers n in the dataset exactly as
in the section above (Methods, Defining cut off levels).
The full lodsratio ranking list was used when calculating
each lodsratio Bpi.
A simple significance level (p-value) for each protein set
was calculated as
where I{•} is equal to 1 if the argument is true and 0 oth-
erwise.
It is difficult to define cut-offs for the p-values (see Discus-
sion; The false discovery rate (FDR) and significance lev-
els). We propose to standardize the p-values for each
comparison and plot them in quantile-quantile (qq)-
plots versus the standard deviations of the set specific p-
values across comparisons.
Let i = 1,...,b be an index over the comparisons and j =
1,...,n be an index over the n = 47 protein sets. For each p-
value pij we computed standardized p-values as
We plotted each of the series P'i1 ,...,P'in versus the series of
standard deviations sj,...sn where sj = sd (P1j,...,Pbj) in six qq-
plots. The x-coordinates (sj) are equal in all the plots and
allow avoiding assumptions about the distribution of the
p-values.
A regression line, based on the standardized p-values
between the first and third quartile is fitted to each qq-
plot. We chose a relative cut-off at -0.9 (×S.d.) by inspec-
tion of all comparisons and transformed the cut-offs back
to the original scales so that it can be compared to the
original p-values.
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DvL – Comparison between Dysk and Ldopa treated ani-
mals
DvM – Comparison between Dysk and Mptp treated ani-
mals
Dysk – Treatment with MPTP and L-DOPA leading to dys-
kinesia
ESI – Electro spray ionization
F – Effect of the fluorescent dye
FDR – False discovery rate (FDR* = n*/n)
GO – Gene Ontology
GSEA – Gene Set Enrichment Analysis
HAc – Acetic acid
IEF – Isoelectric focusing
IPG – Immobilized pH gradient
L-DOPA – Levodopa
Ldopa – Treatment with Levodopa
log2 – Logarithm with base 2
LvC – Comparison between Ldopa and Ctl treated ani-
mals
LvM – Comparison between Ldopa and Mptp treated ani-
mals
M – log2(Cy5/Cy3)
m – log2(Cy5/Cy2) and log2(Cy3/Cy2)
MCy5 – log2Cy3/(log2Cy5+ log2Cy3+ log2Cy2)/3
MCy3 – log2Cy5/(log2Cy5+ log2Cy3+ log2Cy2)/3
MCy2 – log2Cy2/(log2Cy5+ log2Cy3+ log2Cy2)/3
MPTP – 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Mptp – Treatment with MPTP
MS – Mass Spectrometry
MS/MS – Tandem mass spectrometry or Mass spectrome-
try/Mass spectrometry
MSN – Medium spiny neurons
MvC – Comparison between Mptp and Ctl treated ani-
mals
NCBI – National Center for Biotechnology Information
NH4HCO3 – Ammonium bicarbonate
pI – Isoelectric point
Qq-plot – Quantile-quantile plot
S.d. – Standard deviation
SDS – Sodium dodecyl sulfate
SEM – Standard error of the mean
TCA – Tricarboxylic acid
TFA – Trifluoroacetic acid
Tris-HCl – 2-Amino-2-(hydroxymethyl)-1,3-propanediol,
hydrochloride
Vsn – Variance stabilization normalization
Xcorr – Charge state vs. cross-correlation number
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